Which pharmaceutical product achieved the fastest path to $1 billion in sales, reaching this milestone within just 3 months of its 2014 launch due to its revolutionary treatment approach for a previously difficult-to-treat condition?

In the high-stakes world of pharmaceutical product launches, some medications become industry game-changers. This poll tests your knowledge about one of the most successful drug launches in medical history. Can you identify which medication broke records with its phenomenal market entry strategy, sophisticated patient demographics targeting, and unprecedented first-year sales figures? Test your pharma industry knowledge!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Sovaldi (sofosbuvir) for Hepatitis C
Keytruda (pembrolizumab) for cancer immunotherapy
Tecfidera (dimethyl fumarate) for multiple sclerosis
Eliquis (apixaban) for stroke prevention